|
|
|
Volumn Suppl, Issue , 2005, Pages 5-7
|
|
Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCHOLINE;
AMINO ACID RECEPTOR BLOCKING AGENT;
CARBAMIC ACID DERIVATIVE;
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
GALANTAMINE;
GLUTAMIC ACID;
INDAN DERIVATIVE;
MEMANTINE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NOOTROPIC AGENT;
PIPERIDINE DERIVATIVE;
RIVASTIGMINE;
TACRINE;
ALZHEIMER DISEASE;
CLINICAL TRIAL;
DISEASE MANAGEMENT;
DRUG COMBINATION;
DRUG EFFECT;
HOSPITALIZATION;
HUMAN;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REVIEW;
TREATMENT OUTCOME;
ACETYLCHOLINE;
ALZHEIMER DISEASE;
CHOLINESTERASE INHIBITORS;
CLINICAL TRIALS;
DISEASE MANAGEMENT;
DRUG THERAPY, COMBINATION;
EXCITATORY AMINO ACID ANTAGONISTS;
GALANTAMINE;
GLUTAMIC ACID;
HUMANS;
INDANS;
MEMANTINE;
NOOTROPIC AGENTS;
PHENYLCARBAMATES;
PIPERIDINES;
RECEPTORS, N-METHYL-D-ASPARTATE;
SEVERITY OF ILLNESS INDEX;
TACRINE;
TREATMENT OUTCOME;
|
|
EID: 24044434934
PISSN: 10412972
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (63)
|
